Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 267, 113544
Abstract
No abstract availableKeywords
Funding Information
- Shanghai University of Traditional Chinese Medicine (2020LK017)
- National Natural Science Foundation of China (81503343)
- National Natural Science Foundation of China (81273728)
This publication has 26 references indexed in Scilit:
- Poly‐pharmacokinetic Study of a Multicomponent Herbal Medicine in Healthy Chinese VolunteersClinical Pharmacology & Therapeutics, 2017
- The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel diseaseUnited European Gastroenterology Journal, 2017
- New therapeutic concepts in bile acid transport and signaling for management of cholestasisHepatology, 2017
- Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapyGut, 2017
- Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanismJournal of Ethnopharmacology, 2016
- Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBDGut, 2016
- Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota AlterationsCell Host & Microbe, 2016
- Consequences of bile salt biotransformations by intestinal bacteriaGut Microbes, 2016
- Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosisBMC Complementary and Alternative Medicine, 2012
- Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathwayBMC Complementary and Alternative Medicine, 2012